PRAX PDUFA decision: Friday, January 29, 2027

…de HCl&#59; FDA identified no major safety or efficacy concerns to date and does not plan to request an advisory committee meeting&#59; PDUFA date of January 29, 2027 Mid-cycle meeting completed for relutrigine&#59; FDA identified no major safety or efficacy concerns to date and does not plan to re

Dates are sourced from official registries and filings and can change — estimated dates (marked ~) slip routinely. This page updates automatically when the source registry moves the date. Research information only, not investment advice.